Literature DB >> 21203821

Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009).

Paolo Boffetta1, Graham A Colditz, John D Potter, Laurence Kolonel, Paula J Robson, Reza Malekzadeh, Daniela Seminara, Ellen L Goode, Keun-Young Yoo, Paul Demers, Richard Gallagher, Ross Prentice, Yutaka Yasui, Kieran O'Doherty, Gloria M Petersen, Cornelia M Ulrich, Ilona Csizmadi, Ernest K Amankwah, Nigel T Brockton, Karen Kopciuk, S Elizabeth McGregor, Linda E Kelemen.   

Abstract

Epidemiologic studies have adapted to the genomics era by forming large international consortia to overcome issues of large data volume and small sample size. Whereas both cohort and well-conducted case-control studies can inform disease risk from genetic susceptibility, cohort studies offer the additional advantages of assessing lifestyle and environmental exposure-disease time sequences often over a life course. Consortium involvement poses several logistical and ethical issues to investigators, some of which are unique to cohort studies, including the challenge to harmonize prospectively collected lifestyle and environmental exposures validly across individual studies. An open forum to discuss the opportunities and challenges of large-scale cohorts and their consortia was held in June 2009 in Banff, Canada, and is summarized in this report.

Entities:  

Mesh:

Year:  2011        PMID: 21203821      PMCID: PMC8933638          DOI: 10.1007/s10552-010-9717-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  24 in total

1.  The Canadian Partnership for Tomorrow Project: building a pan-Canadian research platform for disease prevention.

Authors:  Marilyn J Borugian; Paula Robson; Isabel Fortier; Louise Parker; John McLaughlin; Bartha Maria Knoppers; Karine Bédard; Richard P Gallagher; Sandra Sinclair; Vincent Ferretti; Heather Whelan; David Hoskin; John D Potter
Journal:  CMAJ       Date:  2010-04-26       Impact factor: 8.262

2.  Ethics. Identifiability in genomic research.

Authors:  William W Lowrance; Francis S Collins
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

3.  The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years.

Authors:  Kjersti S Rønningen; Liv Paltiel; Helle M Meltzer; Rannveig Nordhagen; Kari K Lie; Ragnhild Hovengen; Margaretha Haugen; Wenche Nystad; Per Magnus; Jane A Hoppin
Journal:  Eur J Epidemiol       Date:  2006-09-20       Impact factor: 8.082

4.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

5.  Biobanks: transnational, European and global networks.

Authors:  Martin Asslaber; Kurt Zatloukal
Journal:  Brief Funct Genomic Proteomic       Date:  2007-10-04

Review 6.  Tumour banks: well-guarded treasures in the interest of patients.

Authors:  J Wolter Oosterhuis; Jan Willem Coebergh; Evert-Ben van Veen
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

7.  Breast cancer after use of estrogen plus progestin in postmenopausal women.

Authors:  Rowan T Chlebowski; Lewis H Kuller; Ross L Prentice; Marcia L Stefanick; JoAnn E Manson; Margery Gass; Aaron K Aragaki; Judith K Ockene; Dorothy S Lane; Gloria E Sarto; Aleksandar Rajkovic; Robert Schenken; Susan L Hendrix; Peter M Ravdin; Thomas E Rohan; Shagufta Yasmeen; Garnet Anderson
Journal:  N Engl J Med       Date:  2009-02-05       Impact factor: 91.245

8.  Prospective study of one million deaths in India: rationale, design, and validation results.

Authors:  Prabhat Jha; Vendhan Gajalakshmi; Prakash C Gupta; Rajesh Kumar; Prem Mony; Neeraj Dhingra; Richard Peto
Journal:  PLoS Med       Date:  2005-12-20       Impact factor: 11.069

9.  Ensuring long-term sustainability of existing cohorts remains the highest priority to inform cancer prevention and control.

Authors:  Graham A Colditz
Journal:  Cancer Causes Control       Date:  2010-01-09       Impact factor: 2.506

10.  Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Authors:  Ann C Mertens; Qi Liu; Joseph P Neglia; Karen Wasilewski; Wendy Leisenring; Gregory T Armstrong; Leslie L Robison; Yutaka Yasui
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 11.816

View more
  8 in total

1.  Carcinogenesis of pancreatic cancer: challenges, collaborations, progress.

Authors:  Gloria M Petersen; Paolo Boffetta
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Invited commentary: future of population studies--defining research priorities and processes.

Authors:  Ramachandran S Vasan; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2015-03-04       Impact factor: 4.897

3.  Assessment of hepatocyte growth factor in ovarian cancer mortality.

Authors:  Ellen L Goode; Georgia Chenevix-Trench; Lynn C Hartmann; Brooke L Fridley; Kimberly R Kalli; Robert A Vierkant; Melissa C Larson; Kristin L White; Gary L Keeney; Trynda N Oberg; Julie M Cunningham; Jonathan Beesley; Sharon E Johnatty; Xiaoqing Chen; Katelyn E Goodman; Sebastian M Armasu; David N Rider; Hugues Sicotte; Michele M Schmidt; Elaine A Elliott; Estrid Høgdall; Susanne Krüger Kjær; Peter A Fasching; Arif B Ekici; Diether Lambrechts; Evelyn Despierre; Claus Høgdall; Lene Lundvall; Beth Y Karlan; Jenny Gross; Robert Brown; Jeremy Chien; David J Duggan; Ya-Yu Tsai; Catherine M Phelan; Linda E Kelemen; Prema P Peethambaram; Joellen M Schildkraut; Vijayalakshmi Shridhar; Rebecca Sutphen; Fergus J Couch; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-01       Impact factor: 4.254

4.  "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.

Authors:  Tram Kim Lam; Margaret Spitz; Sheri D Schully; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-15       Impact factor: 4.254

Review 5.  Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.

Authors:  Tram Kim Lam; Christine Q Chang; Scott D Rogers; Muin J Khoury; Sheri D Schully
Journal:  Am J Epidemiol       Date:  2015-03-11       Impact factor: 4.897

Review 6.  Collaborative cancer epidemiology in the 21st century: the model of cancer consortia.

Authors:  Michael R Burgio; John P A Ioannidis; Brett M Kaminski; Eric Derycke; Scott Rogers; Muin J Khoury; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

7.  Grand challenges in cancer epidemiology and prevention.

Authors:  Farhad Islami; Farin Kamangar; Paolo Boffetta
Journal:  Front Oncol       Date:  2011-04-27       Impact factor: 6.244

8.  Joanne Knight Breast Health Cohort at Siteman Cancer Center.

Authors:  Graham A Colditz; Debbie L Bennett; Jennifer Tappenden; Courtney Beers; Nicole Ackermann; Ningying Wu; Jingqin Luo; Sarah Humble; Erin Linnenbringer; Kia Davis; Shu Jiang; Adetunji T Toriola
Journal:  Cancer Causes Control       Date:  2022-01-21       Impact factor: 2.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.